Skip to Main Content

Author Details

Michaela Bowden
Dana-Farber Cancer Institute
2002
53
30
PMIDPaper TitleJournal TitlePublished Year
35362046Hallmarks of Resistance to Immune-Checkpoint Inhibitors.Cancer Immunol Res2022
32238470Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.J Immunother Cancer2020
33208770Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer.Sci Rep2020
32913135Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell-Level PI3K Pathway Activation.Clin Cancer Res2020
32868381Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.Cancer Res2020
31548719Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'.Nat Genet2019
31501535Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.Nat Med2019
31411988Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.Eur Urol Oncol2019
31212389Circulating inflammation markers and prostate cancer.Prostate2019
31263286Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.Nat Med2019
28676564Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR).Gut2018
301837893D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade.Lab Chip2018
30153220Characterization of the Neuroendocrine Tumor Immune Microenvironment.Pancreas2018
30087114BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in <i>Kras</i>-Mutant Non-Small Cell Lung Cancer.Cancer Immunol Res2018
30469014Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration.iScience2018
29101163CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.Cancer Discov2018
29101162<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.Cancer Discov2018
27899381Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6.Cancer Res2017
28487100Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.J Urol2017
29061967High grade serous ovarian carcinomas originate in the fallopian tube.Nat Commun2017
28856682Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.Int J Cancer2017
28507152Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.Proc Natl Acad Sci U S A2017
28903345Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.Oncotarget2017
28900608Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer.Front Oncol2017
28899973TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.Clin Cancer Res2017
28871082Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.Nat Commun2017
28611215Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.Proc Natl Acad Sci U S A2017
28923932Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit.Proc Natl Acad Sci U S A2017
28764807AKT1<sup>low</sup> quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer.Breast Cancer Res2017
28679620Integrated single-cell genetic and transcriptional analysis suggests novel drivers of chronic lymphocytic leukemia.Genome Res2017
28057717Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment.Mol Cancer Res2017
27111282Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles.Nat Med2016
26419959MicroRNA MIR21 and T Cells in Colorectal Cancer.Cancer Immunol Res2016
27980733The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study.Cancer Metab2016
27825638Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.Lancet Oncol2016
27351382Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.Br J Cancer2016
27410923Ipilimumab for Patients with Relapse after Allogeneic Transplantation.N Engl J Med2016
26941287The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women.Cancer Res2016
26000489Integrative clinical genomics of advanced prostate cancer.Cell2015
29900095Profiling the tumor microenvironment proteome in prostate cancer using laser capture microdissection coupled to LCâ¿¿MSâ¿¿A technical report.EuPA Open Proteom2015
28843286Integrative Clinical Genomics of Advanced Prostate Cancer.Cell2015
26457646The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.Nat Genet2015
26289068Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer Activity.Clin Cancer Res2015
25117710Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.Cancer Cell2014
25365225Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth.J Clin Invest2014
22175119Service redesign. A change is in the air.Health Serv J2011
18676588Use of colorimetric test strips for monitoring the effect of hemodialysis on salivary nitrite and uric acid in patients with end-stage renal disease: a proof of principle.Clin Chem2008
17435144Microsensor arrays for saliva diagnostics.Ann N Y Acad Sci2007
16131069Development of a microfluidic platform with an optical imaging microarray capable of attomolar target DNA detection.Anal Chem2005
15007449CO2 laser microfabrication of an integrated polymer microfluidic manifold for the determination of phosphorus.Lab Chip2003
  • 1 - 50 of 53

Recommended Authors

Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 16
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 13
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 26
Richard A Moffitt
Stony Brook University, and Stony Brook Cancer Center
Career Start Year 2005
Number of shared co-authors 6
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Career Start Year 2004
Number of shared co-authors 16
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 12
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 5
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 9
Winston Patrick Kuo
Harvard School of Dental Medicine
Career Start Year 2001
Number of shared co-authors 0
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 30
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 6
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 10
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 18
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 2
David Cogdell
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Muneesh Tewari
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 22
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 2
Peter Kuhn
University of Tubingen
Career Start Year 1994
Number of shared co-authors 6
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 2
Mei He
Sichuan University
Career Start Year 1992
Number of shared co-authors 1
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 4
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 5
Sonata Jarmalaite
Institute of Biosciences, Vilnius University
Career Start Year 1989
Number of shared co-authors 0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 20
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 3
Johan Lindberg
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 5
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 14
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 37

Collaborators

Massimo Loda
Weill Medical College of Cornell University
Co-authored papers 15
Rosina T Lis
National Cancer Institute
Co-authored papers 9
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Myles Brown
Co-authored papers 5
Lorelei A Mucci
Co-authored papers 5
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 4
Elena Ivanova
Dana-Farber Cancer Institute
Co-authored papers 4
Stephanie A Wankowicz
University of California San Francisco
Co-authored papers 4
Mary-Ellen Taplin
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Co-authored papers 4
Edward L Giovannucci
Harvard T.H. Chan School of Public Health
Co-authored papers 4
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Co-authored papers 4
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 4
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 4
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 3
Giovanni Parmigiani
Dana Farber Cancer Institute.
Co-authored papers 3
David R Walt
Brigham and Women's Hospital
Co-authored papers 3
Peter S Hammerman
Novartis Institutes for BioMedical Research
Co-authored papers 3
Stephen R Pennington
UCD Conway Institute, University College Dublin
Co-authored papers 3
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers 2
Raphael Bueno
Co-authored papers 2
Christine Brennan
University of Michigan ann arbor
Co-authored papers 2
Manaswi Gupta
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 2
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 2
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 2
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Co-authored papers 2
Kathryn L Penney
Co-authored papers 2
Catherine J Wu
Co-authored papers 2
Susana Miranda
The Institute of Cancer Research
Co-authored papers 2
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Co-authored papers 2
Release 1.2